Scutellarin enhances anti-tumor immune responses by reducing
TNFR2-expressing CD4+Foxp3+ regulatory T cells
Abstract
Background and Purpose One characteristic of tumor-infiltrating
CD4+Foxp3+ regulatory T cells (Tregs) is high expression of tumor
necrosis factor receptor II (TNFR2), a receptor that mediates the
decisive effect of TNF in the activation and expansion of Tregs. There
is increasing evidence that inhibition of TNFR2 can enhance anti-tumor
immune responses. Therefore, we screened Chinese herbal extracts for
their capacity to blockade of TNF-TNFR2 interaction. Experimental
Approach The inhibitory effect of Chinese herbal extracts and their
containing compounds on the biological consequence of TNF-TNFR2
interaction was initially examined with WEHI-13VAR cells and then
verified by the primary TNFR2+ Tregs. The resultant small molecule TNFR2
inhibitor on the expansion of Tregs in tumor environment was
investigated in mouse CT26 colon model. The effect of such compound on
the efficacy of CpG oligodeoxynucleotide in the treatment of tumor was
further evaluated with same model. Key Results The results showed that
one Chinese herb extract was able to inhibit TNF/TNFR2-induced death of
WEHI-13VAR cells and TNF-induced proliferation of TNFR2+ Tregs. Our
subsequent study found that flavonoid compound scutellarin was
responsible for the activity. Importantly, scutellarin treatment
markedly enhanced the efficacy of tumor immunotherapy with CpG
oligodeoxynucleotide in mouse CT26 colon cancer model. This effect of
scutellarin was associated with the reduction of tumor-infiltrating
TNFR2-expressing Tregs, and increased tumor infiltration of
IFN-–producing CD8+ T cells. Conclusion and Implications Scutellarin
has activities in the inhibition of Tregs expansion induced by TNF-TNFR2
interaction. Our result also suggests that scutellarin or its analogues
may be useful as an adjuvant to enhance anti-tumor effect of
immunotherapy.